Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06629142 · ClinicalTrials.gov registry record · NA
Comparing Optimized Models of Primary And Specialist Services for Palliative Care: Pilot Feasibility Trial
A NA study of Seriously Ill Hospitalized Patients, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,208
- Enrollment target
- 2
- Study locations
NCT06629142: Completed NA study of Seriously Ill Hospitalized Patients, sponsored by University of Pennsylvania.
NCT06629142 is a NA study of Seriously Ill Hospitalized Patients that has completed, run by University of Pennsylvania. The registered enrollment target is 1,208 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06629142, a NA study of Seriously Ill Hospitalized Patients, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,208 participants
- Enrollment target
- 2
- Study locations
Study Summary
Palliative care (PC) seeks to reduce suffering and improve quality of life for patients with serious illnesses and their families. National guidelines recommend that clinicians either provide palliative care themselves (generalist PC) or consult experts (specialist PC) as a standard part of serious illness care. This feasibility pilot study will be conducted with 6 hospitals at two large U.S. health systems and enroll 540 seriously ill hospitalized patients. Eligibility is determined by a mortality prediction score where enrolled patients have at least a 60% risk of dying within 1 year. Enrollment assessment occurs as close as possible to 36 hours post admission. In this cluster-randomized trial, the 6 hospitals will be randomized to 3 arms: (1) standardized usual care, (2) trained generalist PC, or (3) specialist PC. Generalists are trained using the Center to Advance Palliative Care (CAPC) online trainings. The pilot study will only measure process outcomes to assess the feasibility of a larger clinical trial (e.g., are the interventions working as intended). This pilot feasibility study is the precursor to a much larger pragmatic, hybrid effectiveness-implementation parallel-cluster RCT that will assess the comparative effectiveness of triggering generalist PC and specialist PC on several patient-centered outcome measures.
Primary Outcome
Percentage of all Intervention Our Practice Advisory (OPAs) that fired in the correct time window for patients with mortality risk thresholds eligible for each intervention.
Conditions Studied
Interventions
- BEHAVIORAL Default Order
- BEHAVIORAL Accountable Justification
- BEHAVIORAL Standardized Usual Care
Study Locations (2)
California
- Kaiser Permanente Southern California - Pasadena
Michigan
- Trinity Health - Livonia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,208 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2025-07-01 |
| Phase | NA |
What the finished NCT06629142 record still lists
NCT06629142 is an interventional study that assigns participants to a tested intervention. Its 1,208 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Seriously Ill Hospitalized Patients appearing as the primary indexed condition, and to 3 interventions - of which Default Order is the first listed.
NCT06629142 reports a single indexed study location in California, Michigan.
Frequently Asked Questions
What is clinical trial NCT06629142 about?
NCT06629142 is a clinical study titled "Comparing Optimized Models of Primary And Specialist Services for Palliative Care: Pilot Feasibility Trial". Palliative care (PC) seeks to reduce suffering and improve quality of life for patients with serious illnesses and their families. National guidelines recommend that clinicians either provide palliative care themselves (generalist PC) or consult experts (specialist PC) as a standard part of serious ...
What is the current status of trial NCT06629142?
This trial is currently completed. It is a NA study. The enrollment target is 1,208 participants. The study started on 2024-10-17. Estimated completion is 2025-07-01.
What conditions does trial NCT06629142 study?
This clinical trial studies the following conditions: Seriously Ill Hospitalized Patients.
What interventions are being tested in trial NCT06629142?
The interventions under investigation include: Default Order (BEHAVIORAL), Accountable Justification (BEHAVIORAL), Standardized Usual Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06629142?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06629142 being conducted?
This trial has 2 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06629142's enrollment target sits among peer trials
1,208 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946213 · 1,209 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI